Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00090428 · ClinicalTrials.gov registry record · Phase 1
Diet and Behavior in Young Children With Autism
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00090428: Completed Phase 1 study, sponsored by University of Rochester.
NCT00090428 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 21 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00090428, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will determine whether a gluten- and casein-free diet has specific benefits for children with autism.
Primary Outcome
Behavioral data: activity, sleep, behaviors related to the autism; Medical data: stool pattern, nutrition
Interventions
- BEHAVIORAL Gluten- and casein-free diet
- BEHAVIORAL Placebo controlled diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2004-01 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
What the finished NCT00090428 record still lists
NCT00090428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Gluten- and casein-free diet is the first listed.
NCT00090428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00090428 about?
NCT00090428 is a clinical study titled "Diet and Behavior in Young Children With Autism". This study will determine whether a gluten- and casein-free diet has specific benefits for children with autism.
What is the current status of trial NCT00090428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2004-01. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00090428?
The interventions under investigation include: Gluten- and casein-free diet (BEHAVIORAL), Placebo controlled diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00090428?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00090428's enrollment target sits among peer trials
21 1615th of 2000 higher than 372 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia